NCT05679557 Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy
| NCT ID | NCT05679557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aarhus University Hospital |
| Condition | Bladder Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2023-02-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with muscle-invasive bladder cancer are often older and multimorbid, thus in an increased risk of perioperative mortality and morbidity in relation to radical cystectomy (RC). The aim of the study is to investigate the effect of perioperative Comprehensive Geriatric Assessment (CGA) and tailored intervention in older, frail patients with bladder cancer undergoing RC.
Eligibility Criteria
Inclusion Criteria: 1. Patients with muscle-invasive bladder cancer and scheduled radical cystectomy. 2. Planned urinary diversion with an ileal conduit 3. Age ≥ 65 years. 4. Patients considered frail by G8 screening tool (total score ≤14). Exclusion Criteria: 1. Patients who refuse or are not able to provide informed consent. 2. Patients who do not speak or understand Danish. 3. Planned concomitant nephroureterectomy or other major surgical intervention at the same time as RC
Contact & Investigator
Jørgen S Bjerggaard Jensen, Prof., DMSc
PRINCIPAL INVESTIGATOR
Aarhus University Hospital and Aarhus University
Frequently Asked Questions
Who can join the NCT05679557 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05679557 currently recruiting?
Yes, NCT05679557 is actively recruiting participants. Contact the research team at katans@rm.dk for enrollment information.
Where is the NCT05679557 trial being conducted?
This trial is being conducted at Odense, Denmark.
Who is sponsoring the NCT05679557 clinical trial?
NCT05679557 is sponsored by Aarhus University Hospital. The principal investigator is Jørgen S Bjerggaard Jensen, Prof., DMSc at Aarhus University Hospital and Aarhus University. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.